Zhen Bo Su
Direttore/Membro del Consiglio presso CASI PHARMACEUTICALS, INC.
Profilo
Zhen Bo Su is the founder of Chongqing TCR CURE Biopharma Technology Co., Ltd, which was founded in 2016.
Mr. Su's current jobs include being an Independent Director at CASI Pharmaceuticals, Inc. since 2023, a Managing Partner at Shenzhen Share Investment LP, a Partner at Redhill Capital Investment Management Co. Ltd., and a Partner at Guangzhou Redhill Capital Investment Management Co., Ltd.
Mr. Su's former jobs include being an Executive Director at Polyrey Medical Tech (Suzhou) Co., Ltd., Genetron Holdings Ltd., TCRCcure Biopharma Ltd., Meyer FSMP Hong Kong Ltd., and LIGHT VISION CO., LTD.
Mr. Su's education history includes an MBA from The University of Chicago, a graduate degree from Sun Yat-Sen University, and an undergraduate degree from Guangdong Medical University.
Posizioni attive di Zhen Bo Su
| Società | Posizione | Inizio |
|---|---|---|
| CASI PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 21/03/2023 |
Shenzhen Share Investment LP
 Shenzhen Share Investment LP Investment ManagersFinance Shenzhen Share Investment LP is an independent venture capital firm founded in 2007 by Bai Wen Tao, Cui Xin Xin, and Huang Fan Zhi. The firm is headquartered in Shenzhen, China. | Direttore/Membro del Consiglio | - |
| Redhill Capital Investment Management Co. Ltd. | Corporate Officer/Principal | - |
Precedenti posizioni note di Zhen Bo Su
| Società | Posizione | Fine |
|---|---|---|
| Meyer FSMP Hong Kong Ltd. | Direttore/Membro del Consiglio | - |
| LIGHT VISION CO., LTD. | Direttore/Membro del Consiglio | - |
Polyrey Medical Tech (Suzhou) Co., Ltd.
 Polyrey Medical Tech (Suzhou) Co., Ltd. Medical SpecialtiesHealth Technology Polyrey Medical Tech (Suzhou) Co., Ltd. engages in the development, manufacture, and sale of medical instruments in treating vascular diseases. It focuses on coronary catheterization and outer periphery balloon dilatation catheters. The company was founded by Lie Tang on August 3, 2011 and is headquartered in Suzhou, China. | Direttore/Membro del Consiglio | - |
| GENETRON HOLDINGS LIMITED | Direttore/Membro del Consiglio | - |
| TCRCcure Biopharma Ltd. | Direttore/Membro del Consiglio | - |
Formazione di Zhen Bo Su
| The University of Chicago | Masters Business Admin |
| Sun Yat-Sen University | Graduate Degree |
| Guangdong Medical University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CASI PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 8 |
|---|---|
Polyrey Medical Tech (Suzhou) Co., Ltd.
Polyrey Medical Tech (Suzhou) Co., Ltd. Medical SpecialtiesHealth Technology Polyrey Medical Tech (Suzhou) Co., Ltd. engages in the development, manufacture, and sale of medical instruments in treating vascular diseases. It focuses on coronary catheterization and outer periphery balloon dilatation catheters. The company was founded by Lie Tang on August 3, 2011 and is headquartered in Suzhou, China. | Health Technology |
Genetron Holdings Ltd.
 Genetron Holdings Ltd. Medical/Nursing ServicesHealth Services Genetron Holdings, Ltd. engages in precision oncology. It provides cancer molecular profiling by using technologies in molecular biology and data science to transform cancer treatment. It products and services include diagnosis and monitoring through both LDT and IVD products. Its LDT portfolio consists of both specifically designed focused and comprehensive gene panel testing services. It also develops liver cancer early screening products. The company was founded by Si Zhen Wang, Hai Yan, and Wei Wu He in 2015 and is headquartered in Beijing, China. | Health Services |
Chongqing TCR CURE Biopharma Technology Co., Ltd
 Chongqing TCR CURE Biopharma Technology Co., Ltd Pharmaceuticals: MajorHealth Technology Chongqing TCR CURE Biopharma Technology Co., Ltd is a company that develops immunotherapy for T cell cancer. The company is based in Chongqing, China. and has subsidiaries in China. The Chinese company was founded in 2016 by Wei-Wu He, Zhen Bo Su, Qi-Jing Li, Pin Wang. Qi-Jing Li has been the CEO since 2016. | Health Technology |
| TCRCcure Biopharma Ltd. | |
| Meyer FSMP Hong Kong Ltd. | |
| LIGHT VISION CO., LTD. | |
| Redhill Capital Investment Management Co. Ltd. | |
Shenzhen Share Investment LP
Shenzhen Share Investment LP Investment ManagersFinance Shenzhen Share Investment LP is an independent venture capital firm founded in 2007 by Bai Wen Tao, Cui Xin Xin, and Huang Fan Zhi. The firm is headquartered in Shenzhen, China. | Finance |
- Borsa valori
- Insiders
- Zhen Bo Su
